BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 22542437)

  • 21. Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by next-generation sequencing in Henan, China.
    Tian Y; Zhu X; Lv S; Jia C; Zhang L; Ni M; Xu Y; Peng R; Liu S; Zhao D
    Clin Chim Acta; 2022 Nov; 536():155-161. PubMed ID: 36096209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the molecular spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in a Greek newborns cohort: identification of a novel variant.
    Thodi G; Georgiou V; Molou E; Loukas YL; Dotsikas Y; Biti S; Papadopoulos K; Doulgerakis E
    Clin Biochem; 2012 Oct; 45(15):1167-72. PubMed ID: 22683754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns.
    ter Veld F; Mueller M; Kramer S; Haussmann U; Herebian D; Mayatepek E; Laryea MD; Primassin S; Spiekerkoetter U
    PLoS One; 2009 Jul; 4(7):e6449. PubMed ID: 19649258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Woo HI; Park HD; Lee YW; Lee DH; Ki CS; Lee SY; Kim JW
    Korean J Lab Med; 2011 Jan; 31(1):54-60. PubMed ID: 21239873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California.
    Gallant NM; Leydiker K; Tang H; Feuchtbaum L; Lorey F; Puckett R; Deignan JL; Neidich J; Dorrani N; Chang E; Barshop BA; Cederbaum SD; Abdenur JE; Wang RY
    Mol Genet Metab; 2012 May; 106(1):55-61. PubMed ID: 22424739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.
    Grosse SD; Khoury MJ; Greene CL; Crider KS; Pollitt RJ
    Genet Med; 2006 Apr; 8(4):205-12. PubMed ID: 16617240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.
    Catarzi S; Caciotti A; Thusberg J; Tonin R; Malvagia S; la Marca G; Pasquini E; Cavicchi C; Ferri L; Donati MA; Baronio F; Guerrini R; Mooney SD; Morrone A
    ScientificWorldJournal; 2013; 2013():625824. PubMed ID: 24294134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
    Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
    Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium-chain acyl-CoA dehydrogenase deficiency associated with a novel splice mutation in the ACADM gene missed by newborn screening.
    Grünert SC; Wehrle A; Villavicencio-Lorini P; Lausch E; Vetter B; Schwab KO; Tucci S; Spiekerkoetter U
    BMC Med Genet; 2015 Jul; 16():56. PubMed ID: 26223887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening.
    Nennstiel-Ratzel U; Arenz S; Maier EM; Knerr I; Baumkötter J; Röschinger W; Liebl B; Hadorn HB; Roscher AA; von Kries R
    Mol Genet Metab; 2005 Jun; 85(2):157-9. PubMed ID: 15896661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babies.
    Oerton J; Khalid JM; Besley G; Dalton RN; Downing M; Green A; Henderson M; Krywawych S; Leonard J; Andresen BS; Dezateux C
    J Med Screen; 2011; 18(4):173-81. PubMed ID: 22166308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence.
    Leal J; Wordsworth S; Oerton J; Khalid JM; Dezateux C;
    J Clin Epidemiol; 2014 Oct; 67(10):1131-8. PubMed ID: 24998633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of the most common medium-chain acyl CoA dehydrogenase (MCAD) deficiency mutation (K329E) in the Czech newborn population.
    Kozàk L; Hrabincovà E; Rudolfoà J; Vràbelovà S; Freiberger T
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():49-50. PubMed ID: 11400780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
    Sturm M; Herebian D; Mueller M; Laryea MD; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45110. PubMed ID: 23028790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations causing medium chain acyl-CoA dehydrogenase deficiency: under-representation of the common c.985 A > G mutation in the New York state population.
    Nichols MJ; Saavedra-Matiz CA; Pass KA; Caggana M
    Am J Med Genet A; 2008 Mar; 146A(5):610-9. PubMed ID: 18241067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
    Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C
    J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.